Efficacy of antiangiogenic therapy with TNP-470 in superficial and invasive bladder cancer models in mice
- 1 September 2000
- Vol. 56 (3) , 521-526
- https://doi.org/10.1016/s0090-4295(00)00642-7
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- PROGNOSTIC MARKERS IN BLADDER CANCER: A CONTEMPORARY REVIEW OF THE LITERATUREPublished by Wolters Kluwer Health ,1998
- Antiangiogenic therapy of experimental cancer does not induce acquired drug resistanceNature, 1997
- Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor GrowthCell, 1997
- Angiostatin induces and sustains dormancy of human primary tumors in miceNature Medicine, 1996
- Antitumor Effects of Angiogenesis Inhibitor O-(Chloroacetyl-Carbamoyl) Fumagillol (TNP-470) against Murine Renal Cell CarcinomaJournal of Urology, 1996
- Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinomaCell, 1994
- Angiogenesis.Journal of Biological Chemistry, 1992
- Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growthNature, 1990
- What Is the Evidence That Tumors Are Angiogenesis Dependent?JNCI Journal of the National Cancer Institute, 1990
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971